Embiotic Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 3.00 Cr
as on 23-10-2024
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 28.52 Cr
as on 23-10-2024
- Satisfied Charges ₹ 14.55 Cr
as on 23-10-2024
- Revenue -22.01%
(FY 2023)
- Profit -71.68%
(FY 2023)
- Ebitda -21.32%
(FY 2023)
- Net Worth 3.02%
(FY 2023)
- Total Assets 11.20%
(FY 2023)
About Embiotic Laboratories
The Corporate was formerly known as Emboitic Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹28.52 Cr. The company has closed loans amounting to ₹14.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kantilal Jain, Harish Kantilal, and Bharat Jain serve as directors at the Company.
- CIN/LLPIN
U02423KA1988PTC009394
- Company No.
009394
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Embiotic Laboratories Private Limited offer?
Embiotic Laboratories Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Mineral Supplement, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pain Relief Drugs & Pharmaceuticals, Diclofenac.
Who are the key members and board of directors at Embiotic Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kantilal Jain  | Director | 29-Aug-1988 | Current |
| Harish Kantilal | Director | 29-Aug-1988 | Current |
| Bharat Jain | Additional Director | 22-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Embiotic Laboratories.
Embiotic Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 22.01% decrease. The company also saw a substantial fall in profitability, with a 71.68% decrease in profit. The company's net worth moved up by a moderate rise of 3.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Embiotic Laboratories?
In 2023, Embiotic Laboratories had a promoter holding of 33.52% and a public holding of 66.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Sep 2024 | ₹15.00 Cr | Open |
Others Creation Date: 10 Aug 2016 | ₹0.42 M | Open |
Vijaya Bank Creation Date: 17 Jun 2015 | ₹1.20 M | Open |
How Many Employees Work at Embiotic Laboratories?
Embiotic Laboratories has a workforce of 117 employees as of Sep 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Embiotic Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Embiotic Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
